Assessment of C reactive proteins levels in patients with dental implant failure
Keywords:
C reactive proteins, implants, dentalAbstract
Background: The present study was undertaken for assessing C reactive proteins levels in dental implant failure patients. Materials & methods: A total of 100 patients who were schedule to undergo prosthetic rehabilitation of missing mandibular molars were enrolled. Baseline hematological and biochemical variables were evaluated. All the dental implant procedures were carried out under adequate septic conditions. All the patients were put of prescribed antibiotic therapy postoperatively. All the patients were evaluated radiographically after three months for prognosis. C Reactive proteins levels were evaluated in all the patients and were compared between patients on the basis of prognosis. All the results were recorded in Microsoft excel sheet and were subjected to statistical analysis using SPSS software. Results: Mean C Reactive proteins levels among patients with Dental implant failure and among patients with successful dental implants was 0.89 mg/dL and 0.21 mg/dL respectively. Significant results were obtained while comparing the C Reactive proteins levels among patients with Dental implant failure and among patients with successful dental implants.Conclusion: C Reactive proteins could be used as a successful marker for monitoring the success dental implant therapy.
Downloads
References
Grisar K, Sinha D, Schoenaers J, Dormaar T, Politis C. Retrospective Analysis of Dental Implants Placed Between 2012 and 2014: Indications, Risk Factors, and Early Survival. Int J Oral Maxillofac Implants. 2017 May/June;32(3):649–654.
Chanavaz M. Patient screening and medical evaluation for implant and preprosthetic surgery. J Oral Implantol. 1998;24(4):222-9.
Gómez-de Diego R, Mang-de la Rosa Mdel R, Romero-Pérez MJ, Cutando-Soriano A, López-Valverde-Centeno A. Indications and contraindications of dental implants in medically compromised patients: update. Med Oral Patol Oral Cir Bucal. 2014 Sep 01;19(5):e483-9.
Berglundh T, Armitage G, Araújo MG, Avila-Ortiz G, Blanco J, Camargo PM, et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl 1):S313–8.
Fransson C, Tomasi C, Pikner SS, Gröndahl K, Wennström JL, Leyland AH, et al. Severity and pattern of peri-implantitis-associated bone loss. J Clin Periodontol. 2010;37:442–8.
Korsch M, Obst U, Walther W. Cement-associated peri-implantitis: A retrospective clinical observational study of fixed implant-supported restorations using a methacrylate cement. Clin Oral Implants Res. 2014;25:797–802.
Sanz M, Chapple IL. Working Group 4 of the VIII European Workshop on Periodontology Clinical research on peri-implant diseases: Consensus report of Working Group 4. J Clin Periodontol. 2012;39(Suppl 12):202–6.
Fransson C, Wennström J, Tomasi C, Berglundh T. Extent of peri-implantitis-associated bone loss. J Clin Periodontol. 2009;36:357–63.
Renvert S, Lessem J, Dahlén G, Lindahl C, Svensson M. Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridment of incipient peri-implant infections: A randomizedclinical trial. J Clin Periodontol. 2006;33:362–9.
Fahim Vohra 1, Fahad Alkhudhairy 2, Abdulaziz A Al-Kheraif 3, Zohaib Akram 4, Fawad Javed 5. Peri-implant parameters and C-reactive protein levels among patients with different obesity levels. Clin Implant Dent Relat Res. 2018 Apr;20(2):130-136.
Amin Ur Rahman 1, Saqib Rashid, Rizwana Noon, Zeerak S Samuel, Bing Lu, Wenche S Borgnakke, Ray C Williams. Prospective evaluation of the systemic inflammatory marker C-reactive protein in patients with end-stage periodontitis getting teeth replaced with dental implants: a pilot. Clin Oral Implants Res. 2005 Feb;16(1):128-31.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
